In this section
National Public Health studies the RBFT are currently taking part in:
REMAP-CAP uses a novel and innovative adaptive trial design to evaluate a number of treatment options simultaneously and efficiently. This design is able to adapt in the event of pandemics, and increases the likelihood that patients will receive the treatment that is most likely to be effective for them.
Researchers are assessing whether a number of potential therapeutic treatments can improve health outcomes for patients hospitalised with suspected or confirmed COVID-19.
The Pandemic Respiratory Infection Emergency System Triage (PRIEST) study will enhance the triage of patients using emergency care arriving with suspected respiratory infections and identify the most accurate triage method for predicting severe illness.
ISARIC is an observational study collecting samples and data from patients to help understand the characteristics of the virus, how it replicates, and factors affecting underlying individual susceptibility.
The GenOMICC study will identify the specific genes that cause some people to be susceptible to specific infections and consequences of severe injury.
Over the past year, the Trust has taken part in a wide range of COVID-19 research studies to help find the best evidence-based treatments for our patients.
In addition, the Research and Development (R&D) team has created and led on a number of surveys with staff to help provide vital data to researchers measuring the impact of the COVID-19 outbreak on health workers.
By taking part in this research, we have contributed and supported national public health research studies. By actively playing our part, we are helping to ensure we find safe and effective treatments for COVID-19 patients.
Further studies of national interest are currently in the initial set-up phase or already open and running at site.